loadpatents
Patent applications and USPTO patent grants for Etter; Jeffrey B..The latest application filed is for "oral formulations of cytidine analogs and methods of use thereof".
Patent | Date |
---|---|
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof App 20220105118 - Etter; Jeffrey B. ;   et al. | 2022-04-07 |
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof App 20220079964 - Etter; Jeffrey B. ;   et al. | 2022-03-17 |
Isotopologues Of 5-azacytidine App 20200316099 - Traverse; John F. ;   et al. | 2020-10-08 |
Isotopologues of 5-azacytidine Grant 10,646,503 - Traverse , et al. | 2020-05-12 |
Isotopologues Of 5-azacytidine App 20200101095 - Traverse; John F. ;   et al. | 2020-04-02 |
Isotopologues of 5-azacytidine Grant 10,463,683 - Traverse , et al. No | 2019-11-05 |
Isotopologues Of 5-azacytidine App 20190231803 - Traverse; John F. ;   et al. | 2019-08-01 |
Isotopologues of 5-azacytidine Grant 10,220,050 - Traverse , et al. | 2019-03-05 |
Isotopologues Of 5-azacytidine App 20180153916 - Traverse; John F. ;   et al. | 2018-06-07 |
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof App 20160250246 - BACKSTROM; Jay T. ;   et al. | 2016-09-01 |
Pharmaceutical compositions of cytidine analogs and methods of use thereof Grant 9,393,255 - Tutino , et al. July 19, 2 | 2016-07-19 |
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof App 20150374732 - ETTER; Jeffrey B. ;   et al. | 2015-12-31 |
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof App 20150290228 - BACKSTROM; Jay T. ;   et al. | 2015-10-15 |
Isotopologues Of 5-azacytidine App 20150056280 - TRAVERSE; John F. ;   et al. | 2015-02-26 |
Oral formulations of cytidine analogs and methods of use thereof Grant 8,846,628 - Etter , et al. September 30, 2 | 2014-09-30 |
High-concentration protein formulations and method of manufacture Grant 8,372,798 - Carpenter , et al. February 12, 2 | 2013-02-12 |
Pharmaceutical Compositions Of Cytidine Analogs And Methods Of Use Thereof App 20120196823 - TUTINO; Anthony ;   et al. | 2012-08-02 |
Compositions of allosteric hemoglobin modifiers and methods of making the same Grant 7,847,120 - Quick , et al. December 7, 2 | 2010-12-07 |
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof App 20090286752 - Etter; Jeffrey B. ;   et al. | 2009-11-19 |
Composition for delivery of hematopoietic growth factor App 20090232835 - Rosenthal; Gary J. ;   et al. | 2009-09-17 |
Colon-targeted Oral Formulations Of Cytidine Analogs App 20080057086 - Etter; Jeffrey B. | 2008-03-06 |
Compositions of Allosteric Hemoglobin Modifiers and Methods of Making the Same App 20070293698 - Quick; Al ;   et al. | 2007-12-20 |
Particulate drug-containing products and method of manufacture App 20070116776 - Etter; Jeffrey B. | 2007-05-24 |
Treatment of mucositis using N-acetylcysteine App 20070071824 - Rosenthal; Gary J. ;   et al. | 2007-03-29 |
Treatment of esophagitis App 20070014860 - Rosenthal; Gary J. ;   et al. | 2007-01-18 |
Treatment of proctitis App 20070014861 - Rosenthal; Gary J. ;   et al. | 2007-01-18 |
Flow-through optical assay devices providing laminar flow of fluid samples, and methods of construction thereof Grant 7,153,651 - Drewes , et al. December 26, 2 | 2006-12-26 |
Particulate drug-containing products and method of manufacture Grant 7,125,566 - Etter October 24, 2 | 2006-10-24 |
Compositions of allosteric hemoglobin modifiers and methods of making the same App 20050239893 - Quick, Al ;   et al. | 2005-10-27 |
Device for mass transport assisted optical assays Grant 6,933,112 - Drewes , et al. August 23, 2 | 2005-08-23 |
Composition for delivery of hematopoietic growth factor App 20050147682 - Rosenthal, Gary J. ;   et al. | 2005-07-07 |
Composition for delivery of hematopoietic growth factor App 20050147683 - Rosenthal, Gary J. ;   et al. | 2005-07-07 |
Composition for delivery of hematopoietic growth factor App 20050147684 - Rosenthal, Gary J. ;   et al. | 2005-07-07 |
Particulate drug-containing products and method of manufacture App 20040161467 - Etter, Jeffrey B. | 2004-08-19 |
Treatment of mucositis App 20040141949 - Rosenthal, Gary J. ;   et al. | 2004-07-22 |
Particulate insulin-containing products and method of manufacture Grant 6,761,909 - Etter July 13, 2 | 2004-07-13 |
Treatment of mucositis Grant 6,685,917 - Rosenthal , et al. February 3, 2 | 2004-02-03 |
Particulate drug-containing products and method of manufacture Grant 6,669,960 - Etter December 30, 2 | 2003-12-30 |
Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells Grant 6,649,189 - Talmadge , et al. November 18, 2 | 2003-11-18 |
High-concentration protein formulations and method of manufacture App 20030092607 - Carpenter, John F. ;   et al. | 2003-05-15 |
Treatment of mucositis App 20020119104 - Rosenthal, Gary J. ;   et al. | 2002-08-29 |
Composition for delivery of hematopoietic growth factor App 20020102272 - Rosenthal, Gary J. ;   et al. | 2002-08-01 |
Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells App 20020028515 - Talmadge, James E. ;   et al. | 2002-03-07 |
Particulate drug-containing products and method of manufacture App 20010036480 - Etter, Jeffrey B. | 2001-11-01 |
Methods for detection of gram negative bacteria Grant 5,869,272 - Bogart , et al. February 9, 1 | 1999-02-09 |
Methods for optimizing of an optical assay device Grant 5,639,671 - Bogart , et al. June 17, 1 | 1997-06-17 |
Methods for detection of an analyte Grant 5,541,057 - Bogart , et al. July 30, 1 | 1996-07-30 |
Devices and methods for detection of an analyte based upon light interference Grant 5,482,830 - Bogart , et al. * January 9, 1 | 1996-01-09 |
Devices for detection of an analyte based upon light interference Grant 5,468,606 - Bogart , et al. November 21, 1 | 1995-11-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.